-Reuters
NanoVibronix Provides Update On Expanding Access To PainShield; Receives Interim Results Of Lifecycle Testing; Enactment Of Federal ‘NOPAIN Act’ Could Be A Catalyst
Receives Positive Interim Results of Lifecycle Testing
Enactment of Federal ‘NOPAIN Act' Could Be a Catalyst
NanoVibronix, Inc. (NASDAQ:NAOV) (the "Company"), a medical device company utilizing